CD34 and Sepsis: In recent years, the striking significance of CD34+ vascular progenitors in host defense has promoted numerous lines of investigation for the development therapeutic strategies in sepsis-induced vascular injury, mainly based on CD34+ progenitor transplantation or EV delivery [66].